Cargando…
Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review
BACKGROUND: Patients and their families have become more active in healthcare systems and research. The value of patient involvement is particularly relevant in the area of rare diseases, where patients face delayed diagnoses and limited access to effective therapies due to the high level of uncerta...
Autores principales: | Young, Andrea, Menon, Devidas, Street, Jackie, Al-Hertani, Walla, Stafinski, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741909/ https://www.ncbi.nlm.nih.gov/pubmed/29273068 http://dx.doi.org/10.1186/s13023-017-0738-6 |
Ejemplares similares
-
A checklist for managed access programmes for reimbursement co‐designed by Canadian patients and caregivers
por: Young, Andrea, et al.
Publicado: (2018) -
Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
por: Menon, Devidas, et al.
Publicado: (2015) -
Moving beyond the Court of Public Opinion: A Citizens’ Jury Exploring the Public’s Values around Funding Decisions for Ultra-Orphan Drugs
por: Stafinski, Tania, et al.
Publicado: (2022) -
Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework
por: Paulden, Mike, et al.
Publicado: (2014) -
Capturing the Impact of Patient Portals Based on the Quadruple Aim and Benefits Evaluation Frameworks: Scoping Review
por: Avdagovska, Melita, et al.
Publicado: (2020)